|
|
BioAdvance provides funding to startup life sciences companies in Southeastern Pennsylvania through its $20 million Greenhouse Fund. The Greenhouse Program invests up to $1.25 million in seed-stage companies over the life of an investment. Initial seed investments are up to $500,000 and BioAdvance also provides its funding recipients with business assistance and critical resources as they grow. The program also invests up to $50,000 in pre-seed investments.The firm invests in therapeutics, devices, diagnostics and platform technologies focused on human health. Since its first investments in 2003, BioAdvance has become one of the nation's leading investors providing pre-seed and seed-stage funding. To date, the firm has committed $24.1 million to 35 seed-stage companies and 21 pre-seed investments. BioAdvances portfolio companies are working to develop products to treat health problems including Alzheimer's disease, cancer, obesity, GI disorders, neurological and respiratory illnesses. BioAdvance investments have enabled its portfolio companies to leverage more than $1.6 billion in subsequent capital into the region (from private equity, grants, collaborations and M&A activity). The portfolio has attracted over $900M in follow-on funding.
|
